Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/148554
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tejero Villalba, Rut | - |
dc.contributor.author | Navarro Ponz, Alfons | - |
dc.contributor.author | Campayo Guillaumes, Marc | - |
dc.contributor.author | Viñolas Segarra, Núria | - |
dc.contributor.author | Marrades Sicart, Ramon Ma. | - |
dc.contributor.author | Cordeiro Santanach, Anna | - |
dc.contributor.author | Ruíz Martínez, Marc | - |
dc.contributor.author | Santasusagna, Sandra | - |
dc.contributor.author | Molins López-Rodó, Laureano | - |
dc.contributor.author | Ramírez Ruz, J. (José) | - |
dc.contributor.author | Monzó Planella, Mariano | - |
dc.date.accessioned | 2020-01-23T12:30:56Z | - |
dc.date.available | 2020-01-23T12:30:56Z | - |
dc.date.issued | 2014-07-08 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | http://hdl.handle.net/2445/148554 | - |
dc.description.abstract | Several treatments in non-small cell lung cancer (NSCLC) are histology-dependent, and the need for histology-related markers is increasing. MicroRNAs (miRNAs) are promising molecular markers in multiple cancers and show differences in expression depending on histological subtype. The miRNA family miR-200 has been associated with the regulation of epithelial-mesenchymal (EMT)/mesenchymal-epithelial transition (MET). EMT involves profound phenotypic changes that include the loss of cell-cell adhesion, the loss of cell polarity, and the acquisition of migratory and invasive properties that facilitates metastasis. A dual role for the miR-200 family in the prognosis of several tumors has been related to tumor cell origin. However, the prognostic role and function of miR-200 family in early-stage NSCLC adenocarcinoma and squamous cell carcinoma (SCC) have not been well established. Methods: miRNA expression was determined using TaqMan assays in 155 tumors from resected NSCLC patients. Functional studies were conducted in three NSCLC cell lines: H23, A-549 and HCC-44. Results: High miR-200c expression was associated with shorter overall survival (OS) in the entire cohort (p = 0.024). High miR-200c (p = 0.0004) and miR-141 (p = 0.009) expression correlated with shorter OS in adenocarcinoma - but not in SCC. In the multivariate analysis, a risk score based on miR-141 and miR-200c expression emerged as an independent prognostic factor for OS in the entire cohort (OR, 2.787; p = 0.033) and in adenocarcinoma patients (OR, 10.649; p = 0.002). Functional analyses showed that miR-200c, was related to mesenchymal-epithelial transition (MET) and affected cell migration and E-cadherin levels, while overexpression of miR-141 reduced KLF6 protein levels and produced an increase of secretion of VEGFA in vitro (H23, p = 0.04; A-549, p = 0.03; HCC-44, p = 0.02) and was associated with higher blood microvessel density in patient tumor samples (p<0.001). Conclusion: High miR-141 and miR-200c expression are associated with shorter OS in NSCLC patients with adenocarcinoma through MET and angiogenesis. | - |
dc.format.extent | 9 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Public Library of Science (PLoS) | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0101899 | - |
dc.relation.ispartof | PLoS One, 2014, vol. 9, num. 7, p. e101899 | - |
dc.relation.uri | https://doi.org/10.1371/journal.pone.0101899 | - |
dc.rights | cc-by (c) Tejero Villalba, Rut et al., 2014 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) | - |
dc.subject.classification | Migració cel·lular | - |
dc.subject.classification | Pronòstic mèdic | - |
dc.subject.classification | Histologia | - |
dc.subject.other | Cell migration | - |
dc.subject.other | Prognosis | - |
dc.subject.other | Histology | - |
dc.title | miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 642876 | - |
dc.date.updated | 2020-01-23T12:30:57Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 25003366 | - |
Appears in Collections: | Articles publicats en revistes (Fonaments Clínics) Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
642876.pdf | 1.22 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License